The U.S. FDA will no longer support the production of compounded pergolide for use in horses. The change comes several months after the FDA approved a pergolide mesylate tablet for the treatment of clinical signs associated with PPID in horses.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In